Scaffold Repurposing Reveals New Nanomolar Phosphodiesterase Type 5 (PDE5) Inhibitors Based on Pyridopyrazinone Scaffold: Investigation of In Vitro and In Silico Properties.
Pharmaceutics
; 14(9)2022 Sep 15.
Article
in En
| MEDLINE
| ID: mdl-36145702
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Prognostic_studies
Language:
En
Journal:
Pharmaceutics
Year:
2022
Type:
Article
Affiliation country:
Egypt